We are live on
!
Find out more
Two Seas Capital Portfolio holdings
AUM
$8.68B
Turnover
29.09%
1-Year Est. Return
78.08%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+78.08%
3 Year Est. Return
+344.2%
5 Year Est. Return
+575.95%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
+$540M
(+87%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
78.09%
Holding
37
New
11
Increased
14
Reduced
4
Closed
5
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.7
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sotera Health
SHC
|
+$36.2M |
| 2 |
Calumet Specialty Products
CLMT
|
+$31M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$24.8M |
| 4 |
Immunovant
IMVT
|
+$23.7M |
| 5 |
Talen Energy Corp
TLN
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$11.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$10.2M |
| 3 |
Indivior Pharmaceuticals
INDV
|
+$5.89M |
| 4 |
Arcutis Biotherapeutics
ARQT
|
+$2.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.49% |
| 2 | Miscellaneous | 27.52% |
| 3 | Utilities | 16.32% |
| 4 | Technology | 9.5% |
| 5 | Materials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Alphabet (Google) Class A
GOOGL
$4.17T
| $4.73M | 0.41% |
25,000
-15,000
| -38% | -$2.62M |
2024 Q1
3 quarters
|
|
27
Sable Offshore Corp
SOC
$637M
| $3.63M | 0.31% |
+158,518
| New | +$3.47M |
2024 Q4
0 quarters
|
|
28
USA Today Co
TDAY
$1.02B
| $2.53M | 0.22% |
+500,000
| New | +$2.66M |
2024 Q4
0 quarters
|
|
29
Core Scientific Inc Tranche 1 Warrants
CORZW
$664M
| $2.31M | 0.2% |
280,248
| – | – |
2024 Q1
3 quarters
|
|
30
Bit Digital
BTBT
$346M
| $1.94M | 0.17% |
662,414
+250,000
| +61% | +$983K |
2024 Q3
1 quarter
|
|
31
Odyssey Marine Exploration
OMEX
$37.6M
| $1.84M | 0.16% |
2,549,049
+2,449,049
| +2,449% | +$1.24M |
2021 Q4
12 quarters
|
|
|
32
Arcutis Biotherapeutics
ARQT
$3.62B
| – | – |
-312,122
| Closed | -$2.9M | – |
|
|
33
CALL
Exelixis
EXEL
$15.4B
| – | – |
-907,900
| Closed | -$23.6M | – |
|
|
34
Exelixis
EXEL
$15.4B
| – | – |
-453,103
| Closed | -$11.8M | – |
|
35
PUT
Pacira BioSciences
PCRX
$1.45B
| – | – |
-158,400
| Closed | -$2.38M | – |
|
36
TeraWulf
WULF
$5.83B
| – | – |
-432,626
| Closed | -$2.02M | – |
|
Similar funds
GA
Two Seas Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Two Seas Capital held 37 positions worth $1.16B, up 87% from $617M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Two Seas Capital deployed $200M of net new capital in Q4 2024, opening 11 new positions and adding to 14 existing holdings. Its largest new stake was Adaptimmune Therapeutics: 14,835,146 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 57% a quarter earlier, followed by Miscellaneous and Utilities.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $10.2M trimmed.
- Two Seas Capital's largest Q4 2024 buy was Adaptimmune Therapeutics: 14,835,146 shares worth $7.99M.
- Two Seas Capital added most to Sotera Health in Q4 2024, an estimated $36.2M increase.
- Two Seas Capital's biggest Q4 2024 reduction was Meta Platforms (Facebook), cutting an estimated $10.2M.
- Two Seas Capital fully exited Exelixis in Q4 2024, selling an estimated $11.8M.
- Two Seas Capital's ten largest holdings make up 78% of its $1.16B portfolio in Q4 2024.
- Two Seas Capital opened 11 new positions and closed 5 in Q4 2024.
- Two Seas Capital's portfolio value rose 87% quarter-over-quarter to $1.16B.
Based on Two Seas Capital's 13F filing for Q4 2024, filed 14 Feb 2025.